{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:47:41Z","timestamp":1775044061291,"version":"3.50.1"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>\n                    Kawasaki disease (KD) is the leading cause of acquired cardiovascular disease in children and is characterized by intense immune activation and platelet dysfunction. High platelet reactivity (HPR) is increasingly recognized as a biological basis of aspirin resistance (AR), which may increase the risk of adverse coronary outcomes, including coronary artery aneurysms (CAA). However, the hematologic dynamics and genetic determinants underlying AR in KD remain unclear. In this study, the association between AR and CAA was assessed using chi-square analysis. We compared platelet parameters between KD aspirin-resistant (KD-AR) and KD non-aspirin-resistant (KD-NAR) patients across different disease phases using linear mixed-effects models (LMM). Baseline complete blood count (CBC) derived inflammatory indices, including the systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR), and neutrophil-to-lymphocyte ratio (NLR), were evaluated using restricted cubic spline (RCS) and receiver operating characteristic (ROC) analyses. Integrated transcriptomic and expression quantitative trait loci (eQTL) analyses were performed to identify candidate genetic factors associated with the KD-AR phenotype. The results showed that AR was significantly associated with CAA formation. LMM showed significant phase-dependent changes in platelet parameters, with distinct longitudinal trajectories between KD-AR and KD-NAR patients. Between-group differences were mainly observed during the subacute phase (D7\u201314), when KD-AR patients showed lower platelet count (PLT) and plateletcrit (PCT), but higher platelet distribution width (PDW) and platelet large cell ratio (PLCR). Baseline SII, PLR, and NLR were significantly elevated in KD-AR patients (all\n                    <jats:italic>P<\/jats:italic>\n                    &amp;lt; 0.001). RCS analyses demonstrated significant overall associations between these indices and AR risk (all\n                    <jats:italic>P<\/jats:italic>\n                    <jats:sub>overall<\/jats:sub>\n                    &amp;lt; 0.001). ROC analyses showed moderate discrimination for SII (AUC = 0.702) and NLR (AUC = 0.722), whereas PLR showed lower performance (AUC = 0.626).\n                    <jats:italic>MBP<\/jats:italic>\n                    was consistently upregulated in HPR-associated samples, and eQTL integration identified\n                    <jats:italic>MBP\/rs8090438<\/jats:italic>\n                    as a candidate variant linked to KD-AR. These findings suggest that AR in KD represents a multifactorial phenotype involving immune-driven platelet dysregulation and genetic susceptibility. Baseline inflammatory indices, particularly NLR and SII, may assist in early identification of KD patients at increased likelihood of AR.\n                  <\/jats:p>","DOI":"10.3389\/fmolb.2026.1807254","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:20:31Z","timestamp":1775038831000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Platelet-related hematologic markers and genetic associations of aspirin resistance in kawasaki disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Linjie","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Cardiac Center, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University","place":["Guangzhou, China"]},{"name":"Department of Clinical Biological Resource Bank, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoting","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion, Guangzhou Medical University, Guangzhou Women and Children\u2019s Medical Center","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiac Center, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University","place":["Guangzhou, China"]},{"name":"Department of Clinical Biological Resource Bank, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University","place":["Guangzhou, China"]},{"name":"Department of Pediatrics, The Affiliated Qingyuan Hospital (Qingyuan People\u2019s Hospital), Guangzhou Medical University","place":["Qingyuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xilian","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Clinical Biological Resource Bank, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University","place":["Guangzhou, China"]},{"name":"Shanghai Public Health Clinical Center & Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute, Shanghai Medical College, Fudan University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaining","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Molecular Medical Center, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanyan","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Clinical Biological Resource Bank, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufen","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Clinical Biological Resource Bank, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huazhong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Clinical Biological Resource Bank, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxue","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Biological Resource Bank, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caiting","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Clinical Biological Resource Bank, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqiong","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Clinical Biological Resource Bank, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University","place":["Guangzhou, China"]},{"name":"Department of Blood Transfusion, Guangzhou Medical University, Guangzhou Women and Children\u2019s Medical Center","place":["Guangzhou, China"]},{"name":"Department of Molecular Medical Center, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangna","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunjiao","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhouping","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiac Center, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianrui","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Cardiac Center, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Pi","sequence":"additional","affiliation":[{"name":"Department of Clinical Biological Resource Bank, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1186\/s12887-024-05202-2","article-title":"Different antithrombotic strategies to prevent cardiovascular complications in kawasaki patients: a systematic review and meta-analysis","volume":"24","author":"Assempoor","year":"2024","journal-title":"BMC Pediatr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1160\/TH12-10-0758","article-title":"High on-treatment platelet reactivity--definition and measurement","volume":"109","author":"Cattaneo","year":"2013","journal-title":"Thromb. Haemost."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e50765","DOI":"10.7759\/cureus.50765","article-title":"Relationship of complete blood count derived biomarkers with methotrexate resistance","volume":"15","author":"Chikovani","year":"2023","journal-title":"Cureus"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e20170098","DOI":"10.1542\/peds.2017-0098","article-title":"Aspirin dose and prevention of coronary abnormalities in Kawasaki disease","volume":"139","author":"Dallaire","year":"2017","journal-title":"Pediatrics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.14797\/mdcj-10-1-13","article-title":"Cardiovascular drugs and the genetic response","volume":"10","author":"Dandona","year":"2014","journal-title":"Methodist Debakey Cardiovasc J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Dav\u00ec","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1160\/TH15-02-0179","article-title":"Antiplatelet drugs in patients with enhanced platelet turnover: biomarkers versus platelet function testing","volume":"114","author":"Freynhofer","year":"2015","journal-title":"Thromb. Haemost."},{"key":"B8","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/TME.0000000000000253","article-title":"Kawasaki disease in infancy","volume":"41","author":"Fuller","year":"2019","journal-title":"Adv. Emerg. Nurs. J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/138161211795049804","article-title":"Mean platelet volume: a link between thrombosis and inflammation?","volume":"17","author":"Gasparyan","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"B10","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1365-2125.2008.03183.x","article-title":"Pharmacogenetics of aspirin resistance: a comprehensive systematic review","volume":"66","author":"Goodman","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.jacc.2009.04.102","article-title":"When children with Kawasaki disease grow up: myocardial and vascular complications in adulthood","volume":"54","author":"Gordon","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/s0002-9149(01)01631-9","article-title":"Profile and prevalence of aspirin resistance in patients with cardiovascular disease","volume":"88","author":"Gum","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/s0735-1097(02)03014-0","article-title":"A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12887-021-03083-3","article-title":"Blood routine risk factors for coronary artery aneurysm in infants younger than 8 months with Kawasaki disease","volume":"22","author":"Haiyan","year":"2022","journal-title":"BMC Pediatr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/01.crd.0000148175.60718.69","article-title":"Aspirin resistance: mechanisms and clinical implications","volume":"14","author":"Hanjis","year":"2006","journal-title":"Cardiol. Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.3390\/biomedicines10102564","article-title":"Genetic association study and machine learning to investigate differences in platelet reactivity in patients with acute ischemic stroke treated with aspirin","volume":"10","author":"Ikonnikova","year":"2022","journal-title":"Biomedicines"},{"key":"B17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1182\/blood.v99.1.193","article-title":"Adenosine diphosphate (ADP)-Induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors","volume":"99","author":"Jin","year":"2002","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.21037\/tp-21-74","article-title":"Effectiveness and safety of dual antiplatelet therapy in coronary aneurysms caused by Kawasaki disease in children: study protocol for a multicenter randomized clinical trial","volume":"10","author":"Li","year":"2021","journal-title":"Transl. Pediatr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"126939","DOI":"10.1016\/j.talanta.2024.126939","article-title":"Highly specific screening of aspirin resistance-related single-nucleotide polymorphisms using ligase chain reaction strategy","volume":"282","author":"Li","year":"2025","journal-title":"Talanta"},{"key":"B20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1515\/cclm-2023-0625","article-title":"Platelet distribution width (PDW) as a significant correlate of COVID-19 infection severity and mortality","volume":"62","author":"Ligi","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12969-025-01162-8","article-title":"Clinical utility of CBC-derived inflammatory markers for predicting IVIG resistance: findings from a Korean infant Kawasaki disease cohort","volume":"23","author":"Lim","year":"2025","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"969502","DOI":"10.3389\/fped.2022.969502","article-title":"Value of blood inflammatory markers for predicting intravenous immunoglobulin resistance in Kawasaki disease: a systematic review and meta-analysis","volume":"10","author":"Liu","year":"2022","journal-title":"Front. Pediatr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1136\/svn-2022-002228","article-title":"Model based on single-nucleotide polymorphism to discriminate aspirin resistance patients","volume":"9","author":"Liu","year":"2024","journal-title":"Stroke Vasc. Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1136\/jim-2021-001810","article-title":"Hemogram as marker of in-hospital mortality in COVID-19","volume":"69","author":"L\u00f3pez-Escobar","year":"2021","journal-title":"J. Investig. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"903","DOI":"10.2217\/bmm-2016-0070","article-title":"Platelet function testing as a biomarker for efficacy of antiplatelet drugs","volume":"10","author":"Lordkipanidz\u00e9","year":"2016","journal-title":"Biomark. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American heart association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"670","DOI":"10.19538\/j.ek2019080613","article-title":"Effect of aspirin on anti-platelet aggregation function in children with Kawasaki disease","volume":"34","author":"Meng","year":"2019","journal-title":"Chin. J. Pract. Pediatr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e180030","DOI":"10.1001\/jamapediatrics.2018.0030","article-title":"Association of severity of coronary artery aneurysms in patients with Kawasaki disease and risk of later coronary events","volume":"172","author":"Miura","year":"2018","journal-title":"JAMA Pediatr."},{"key":"B29","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2174\/1573403X15666190225123544","article-title":"Hematological parameters as prognostic biomarkers in patients with cardiovascular diseases","volume":"15","author":"Monteiro","year":"2019","journal-title":"Curr. Cardiol. Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1055\/s-0036-1572328","article-title":"Platelets as biomarkers of coronary artery disease","volume":"42","author":"Pasalic","year":"2016","journal-title":"Semin. Thromb. Hemost."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"Patrono","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"102652","DOI":"10.1016\/j.rpth.2024.102652","article-title":"Changes in platelet maturity and reactivity following acute ST-segment elevation myocardial infarction","volume":"9","author":"Pedersen","year":"2024","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"B33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11926-020-00941-4","article-title":"Kawasaki disease: an update","volume":"22","author":"Rife","year":"2020","journal-title":"Curr. Rheumatol. Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev-med-042409-151944","article-title":"Kawasaki disease: novel insights into etiology and genetic susceptibility","volume":"62","author":"Rowley","year":"2011","journal-title":"Annu. Rev. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0167-4889(93)90057-v","article-title":"Activation of myelin basic protein and S6 peptide kinases in phorbol ester- and PAF-treated sheep platelets","volume":"1176","author":"Samiei","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"B36","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrrheum.2015.54","article-title":"Kawasaki disease: insights into pathogenesis and approaches to treatment","volume":"11","author":"Shulman","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/ejh.12262","article-title":"An overview of platelet indices and methods for evaluating platelet function in thrombocytopenic patients","volume":"92","author":"Vinholt","year":"2014","journal-title":"Eur. J. Haematol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1111\/jth.13675","article-title":"Measurement of platelet aggregation, independently of patient platelet count: a flow-cytometric approach","volume":"15","author":"Vinholt","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"B39","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.2147\/IJGM.S515118","article-title":"Age-specific cardiovascular and platelet dynamics in Kawasaki disease","volume":"18","author":"Wang","year":"2025","journal-title":"Int. J. Gen. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1399150","DOI":"10.3389\/fimmu.2024.1399150","article-title":"Novel predictors of intravenous immunoglobulin resistance in patients with Kawasaki disease: a retrospective study","volume":"15","author":"Yi","year":"2024","journal-title":"Front. Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1186\/s12888-024-06439-y","article-title":"Neutrophil-to-lymphocyte, platelet-to-lymphocyte ratios and systemic immune-inflammation index in patients with post-traumatic stress disorder","volume":"24","author":"Yontar","year":"2024","journal-title":"BMC Psychiatry"},{"key":"B42","doi-asserted-by":"publisher","first-page":"260","DOI":"10.31083\/j.rcm2308260","article-title":"Assessment of endothelial dysfunction in patients with Kawasaki disease: a meta-analysis","volume":"23","author":"Yu","year":"2022","journal-title":"Rev. Cardiovasc Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e34552","DOI":"10.1016\/j.heliyon.2024.e34552","article-title":"Genetic factors related to aspirin resistance using the multiplate\u00ae device in Hong Kong Chinese patients with stable coronary heart disease","volume":"10","author":"Zeng","year":"2024","journal-title":"Heliyon"},{"key":"B44","doi-asserted-by":"publisher","first-page":"794417","DOI":"10.3389\/fphar.2021.794417","article-title":"Mechanism of improving aspirin resistance: blood-activating herbs combined with aspirin in treating atherosclerotic cardiovascular diseases","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1186\/s12889-024-19105-5","article-title":"Systemic inflammatory biomarkers are novel predictors of all-cause and cardiovascular mortality in individuals with osteoarthritis: a prospective cohort study using data from the NHANES","volume":"24","author":"Zhou","year":"2024","journal-title":"BMC Public Health"}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1807254\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:20:33Z","timestamp":1775038833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1807254\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":45,"alternative-id":["10.3389\/fmolb.2026.1807254"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2026.1807254","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"1807254"}}